
1. clin transl immunology. 2015 mar 27;4(3):e35. doi: 10.1038/cti.2015.5.
ecollection 2015 mar.

adoptive t-cell immunotherapy ganciclovir-resistant cmv disease lung
transplantation.

holmes-liew cl(1), holmes m(1), beagley l(2), hopkins p(3), chambers d(3), smith 
c(2), khanna r(2).

author information: 
(1)south australian lung transplant unit, department thoracic medicine, royal 
adelaide hospital , adelaide, south australia, australia ; faculty health
sciences, school medicine, university adelaide , adelaide, south australia,
australia.
(2)qimr centre immunotherapy vaccine development, qimr berghofer medical 
research institute , brisbane, queensland, australia.
(3)queensland lung transplant service, prince charles hospital , brisbane,
queensland, australia ; school medicine, university queensland ,
brisbane, queensland, australia.

infections cytomegalovirus (cmv) induce severe complications solid
organ transplantation (sot). prognosis ganciclovir-resistant cmv
infection disease particularly poor. whereas adoptive transfer of
cmv-specific cells emerged powerful tool hematopoietic stem cell
transplant patients, translation sot setting remains significant
challenge underlying immunosuppression inhibits virus-specific t-cell
response vivo. here, demonstrate successful expansion adoptive transfer
of autologous cmv-specific cells seronegative recipient a
seropositive lung allograft ganciclovir-resistant cmv disease, resulting 
the long-term reconstitution protective anti-viral immunity, cmv infection,
disease-free survival allograft rejection.

doi: 10.1038/cti.2015.5 
pmcid: pmc4386617
pmid: 25859390 

